Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Yoshimasa Kosaka"'
Autor:
Hiroki Harada, Kei Hosoda, Hiromitsu Moriya, Hiroaki Mieno, Akira Ema, Hideki Ushiku, Marie Washio, Nobuyuki Nishizawa, Satoru Ishii, Kazuko Yokota, Yoko Tanaka, Takeshi Kaida, Takafumi Soeno, Yoshimasa Kosaka, Masahiko Watanabe, Keishi Yamashita
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0214872 (2019)
BackgroundThere have been few available prognostic biomarkers in gastric cancer. We rigorously assessed the clinical relevance of promoter DNA methylation of Cysteine dioxygenase type 1 (CDO1) gene, a cancer-specific aberration, in human gastric canc
Externí odkaz:
https://doaj.org/article/fa84b478afe44ea4b9816d643c67aa82
Autor:
Keita Kojima, Takatoshi Nakamura, Yosuke Ooizumi, Kazuharu Igarashi, Toshimichi Tanaka, Keigo Yokoi, Satoru Ishii, Nobuyuki Nishizawa, Hiroshi Katoh, Yoshimasa Kosaka, Takeo Sato, Masahiko Watanabe, Keishi Yamashita
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0211108 (2019)
Although small bowel cancer (SBC) is extremely rare, its prognosis is poor, and molecular mechanism of the SBC development remains unclear. The aim of our study is to elucidate whether DNA methylation of the promoter region of the cancer-specific met
Externí odkaz:
https://doaj.org/article/dd544dac7cb7469c86a8be93db96757e
Autor:
Yoshimasa Kosaka, Yutaka Yamamoto, Hirokazu Tanino, Hiroshi Nishimiya, Mutsuko Yamamoto-Ibusuki, Yuko Hirota, Hirotaka Iwase, Seigo Nakamura, Sadako Akashi-Tanaka
Publikováno v:
Diagnostics, Vol 10, Iss 2, p 119 (2020)
Triple-negative breast cancer (TNBC) has several subtypes. The identification of markers associated with recurrence and poor prognosis in patients with TNBC is urgently needed. BRCAness is a set of traits in which BRCA1 dysfunction, arising from gene
Externí odkaz:
https://doaj.org/article/9830f6ea7d5245eb8347e4a8df30b57c
Autor:
Jonathan T. Lei, Jieya Shao, Jin Zhang, Michael Iglesia, Doug W. Chan, Jin Cao, Meenakshi Anurag, Purba Singh, Xiaping He, Yoshimasa Kosaka, Ryoichi Matsunuma, Robert Crowder, Jeremy Hoog, Chanpheng Phommaly, Rodrigo Goncalves, Susana Ramalho, Raquel Mary Rodrigues Peres, Nindo Punturi, Cheryl Schmidt, Alex Bartram, Eric Jou, Vaishnavi Devarakonda, Kimberly R. Holloway, W. Victoria Lai, Oliver Hampton, Anna Rogers, Ethan Tobias, Poojan A. Parikh, Sherri R. Davies, Shunqiang Li, Cynthia X. Ma, Vera J. Suman, Kelly K. Hunt, Mark A. Watson, Katherine A. Hoadley, E. Aubrey Thompson, Xi Chen, Shyam M. Kavuri, Chad J. Creighton, Christopher A. Maher, Charles M. Perou, Svasti Haricharan, Matthew J. Ellis
Publikováno v:
Cell Reports, Vol 24, Iss 6, Pp 1434-1444.e7 (2018)
Summary: RNA sequencing (RNA-seq) detects estrogen receptor alpha gene (ESR1) fusion transcripts in estrogen receptor-positive (ER+) breast cancer, but their role in disease pathogenesis remains unclear. We examined multiple ESR1 fusions and found th
Externí odkaz:
https://doaj.org/article/b6b75cb5a81b49bf90d37ac3366f6ea7
Autor:
Keita Kojima, Takatoshi Nakamura, Makoto Ohbu, Hiroshi Katoh, Yosuke Ooizumi, Kazuharu Igarashi, Satoru Ishii, Toshimichi Tanaka, Keigo Yokoi, Nobuyuki Nishizawa, Kazuko Yokota, Yoshimasa Kosaka, Takeo Sato, Masahiko Watanabe, Keishi Yamashita
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0194785 (2018)
Progression of colorectal cancer (CRC) has been explained by genomic abnormalities along with the adenoma-carcinoma sequence theory (ACS). The aim of our study is to elucidate whether the promoter DNA methylation of the cancer-specific methylation ge
Externí odkaz:
https://doaj.org/article/3c33910663a5408cb1e011f16aa0ea78
Autor:
Hirokazu Tanino, Yoshimasa Kosaka, Hiroshi Nishimiya, Youko Tanaka, Naoko Minatani, Mariko Kikuchi, Akiko Shida, Mina Waraya, Hiroshi Katoh, Takumo Enomoto, Norihiko Sengoku, Sabine Kajita, Robert M Hoffman, Masahiko Watanabe
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0165721 (2016)
BRCAness is defined as the set of traits in which BRCA1 dysfunction, arising from gene mutation, methylation or deletion, results in DNA repair deficiency. In the present study, we addressed BRCAness, therapeutic efficacy, recurrence, and survival in
Externí odkaz:
https://doaj.org/article/92117244376b48abbc13c173f35bbb12
Autor:
Naoko Minatani, Mina Waraya, Keishi Yamashita, Mariko Kikuchi, Hideki Ushiku, Ken Kojo, Akira Ema, Hiroshi Nishimiya, Yoshimasa Kosaka, Hiroshi Katoh, Norihiko Sengoku, Hirokazu Tanino, David Sidransky, Masahiko Watanabe
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0144862 (2016)
Using pharmacological unmasking microarray, we identified promoter DNA methylation of cysteine dioxygenase 1 (CDO1) gene in human cancer. In this study, we assessed the clinicopathological significance of CDO1 methylation in primary breast cancer (BC
Externí odkaz:
https://doaj.org/article/07e0cbffe3d148418f91272b8ffc6e4e
Autor:
Yoshimasa Kosaka, Toshiaki Saeki, Toshimi Takano, Tomoyuki Aruga, Toshinari Yamashita, Norikazu Masuda, Yukio Koibuchi, Akihiko Osaki, Junichiro Watanabe, Ryu Suzuki
Publikováno v:
International Journal of Nanomedicine. 17:4567-4578
Yoshimasa Kosaka,1– 3 Toshiaki Saeki,2 Toshimi Takano,4,5 Tomoyuki Aruga,6 Toshinari Yamashita,7 Norikazu Masuda,8,9 Yukio Koibuchi,10 Akihiko Osaki,2 Junichiro Watanabe,11,12 Ryu Suzuki13 1Department of Breast and Endocrine Surgery, Kitasato Unive
Autor:
Kenji Ishido, Takashi Kaizu, Yusuke Kumamoto, Yoshimasa Kosaka, Kiyoshi Tanaka, Takeo Sato, Hiroshi Tajima, Wasaburo Koizumi, Hiroki Harada, Takeshi Naito, Akinori Watanabe, Takafumi Sangai, Naoki Hiki, Hiroshi Kato, Keishi Yamashita, Kei Hosoda, Marie Washio, Takuya Wada, Norihiko Sengoku, Mikiko Sakuraya, Chikatoshi Katada, Masahiro Niihara, Satoshi Tanabe, Hideki Ushiku
Publikováno v:
Langenbeck's Archives of Surgery. 405:777-785
The purpose of this study is to evaluate the long-term survival outcomes of KDOG1001 trial after a minimum follow-up of 3 years. Patients with bulky N2 lymph nodes, linitis plastica (type 4), or large ulcero-invasive-type tumors (type 3) received up
Autor:
Mitsuo Yokota, Mariko Kikuchi, Keishi Yamashita, Hiroshi Nishimiya, Norihiko Sengoku, Hiroshi Katoh, Masahiko Watanabe, Yoshimasa Kosaka
Publikováno v:
Journal of Surgical Research. 246:535-543
A growing body of evidences shows that systemic inflammatory responses are involved in patient prognosis in multiple cancers. Combinations of peripheral leukocyte fractions have been shown to be useful markers for the inflammatory responses. However,